Sign Up Today and Learn More About Abdera Therapeutics Stock
Invest in or calculate the value of your shares in Abdera Therapeutics or other pre-IPO companies through EquityZen's platform.
Abdera Therapeutics Stock (ABTH)
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
About Abdera Therapeutics Stock
Founded
2021
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Abdera Therapeutics Press Mentions
Stay in the know about the latest news on Abdera Therapeutics
Dll3 binding molecules and uses thereof
patents • Apr 02, 2025
Vhh antibody conjugates
patents • Apr 02, 2025
DLL3-BINDING MOLECULES AND THEIR USES
patents • Feb 08, 2025
Dll3 binding molecules and uses thereof
patents • Feb 08, 2025
Immunoconjugates for targeted radioisotope therapy
patents • Feb 08, 2025
Abdera Therapeutics Management
Leadership team at Abdera Therapeutics
Board Member
Garry Nicholson
Interim Chief Executive Officer & Co-Founder
Lana Janes
Join now and verify your accreditation status to gain access to:
- Abdera Therapeutics Current Valuation
- Abdera Therapeutics Stock Price
- Abdera Therapeutics Management
- Available deals in Abdera Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Abdera Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Abdera Therapeutics Revenue and Financials
- Abdera Therapeutics Highlights
- Abdera Therapeutics Business Model
- Abdera Therapeutics Risk Factors
- Abdera Therapeutics Research Report from SACRA Research
Trading Abdera Therapeutics Stock
How to invest in Abdera Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Abdera Therapeutics through EquityZen funds. These investments are made available by existing Abdera Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Abdera Therapeutics stock?
Shareholders can sell their Abdera Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
